Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BRAIN CONSTITUENT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 110 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hanus, L; Abu-Lafi, S; Fride, E; Breuer, A; Vogel, Z; Shalev, DE; Kustanovich, I; Mechoulam, R
      2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1receptor

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    2. Patricelli, MP; Cravatt, BF
      Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase

      BIOCHEMISTRY
    3. Dasse, O; Mahadevan, A; Han, LN; Martin, BR; Di Marzo, V; Razdan, RK
      The synthesis of N-vanillyl-arachidonoyl-amide (arvanil) and its analogs: An improved procedure for the synthesis of the key synthon methyl 14-hydroxy-(all-cis)-5,8,11-tetradecatrienoate

      TETRAHEDRON
    4. Martin, BR; Beletskaya, I; Patrick, G; Jefferson, R; Winckler, R; Deutsch, DG; Di Marzo, V; Dasse, O; Mahadevan, A; Razdan, RK
      Cannabinoid properties of methylfluorophosphonate analogs

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    5. Rakhshan, F; Day, TA; Blakely, RD; Barker, EL
      Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. Di Marzo, V; Breivogel, C; Bisogno, T; Melck, D; Patrick, G; Tao, Q; Szallasi, A; Razdan, RK; Martin, BR
      Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Hao, SZ; Avraham, Y; Mechoulam, R; Berry, EM
      Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    8. Hillard, CJ; Jarrahian, A
      The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes

      CHEMISTRY AND PHYSICS OF LIPIDS
    9. Houser, SJ; Eads, M; Embrey, JP; Welch, SP
      Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide

      BRAIN RESEARCH
    10. Giuffrida, A; de Fonseca, FR; Piomelli, D
      Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry

      ANALYTICAL BIOCHEMISTRY
    11. Costa, B; Giagnoni, G; Colleoni, M
      Precipitated and spontaneous withdrawal in rats tolerant to anandamide

      PSYCHOPHARMACOLOGY
    12. Castellano, C; Ventura, R; Cabib, S; Puglisi-Allegra, S
      Strain-dependent effects of anandamide on memory consolidation in mice areantagonized by naltrexone

      BEHAVIOURAL PHARMACOLOGY
    13. Costa, B; Vailati, S; Colleoni, M
      SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats

      BEHAVIOURAL PHARMACOLOGY
    14. Watanabe, K; Matsunaga, T; Nakamura, S; Kimura, T; Ho, IK; Yoshimura, H; Yamamoto, I
      Pharmacological effects in mice of anandamide and its related fatty acid ethanolamides, and enhancement of cataleptogenic effect of anandamide by phenylmethylsulfonyl fluoride

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    15. Martin, WJ; Loo, CM; Basbaum, AI
      Spinal cannabinoids are anti-allodynic in rats with persistent inflammation

      PAIN
    16. Li, J; Daughters, RS; Bullis, C; Bengiamin, R; Stucky, MW; Brennan, J; Simone, DA
      The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats

      PAIN
    17. Raffa, RB; Stone, DJ; Hipp, SJ
      Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists Delta(9)-THC, WIN 55,212-2 and anandamide in mice

      NEUROSCIENCE LETTERS
    18. Mechoulam, R; Ben-Shabat, S
      From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis

      NATURAL PRODUCT REPORTS
    19. Corchero, J; Manzanares, J; Fuentes, JA
      Repeated administration of Delta(9)-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat

      NEUROPHARMACOLOGY
    20. Akinshola, BE; Taylor, RE; Ogunseitan, AB; Onaivi, ES
      Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    21. Hanus, L; Breuer, A; Tchilibon, S; Shiloah, S; Goldenberg, D; Horowitz, M; Pertwee, RG; Ross, RA; Mechoulam, R; Fride, E
      HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    22. Ishioka, N; Bukoski, RD
      A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    23. Hohmann, AG; Tsou, K; Walker, JM
      Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat

      JOURNAL OF NEUROPHYSIOLOGY
    24. Ng, EW; Aung, MM; Abood, ME; Martin, BR; Razdan, RK
      Unique analogues of anandamide: Arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas

      JOURNAL OF MEDICINAL CHEMISTRY
    25. Mason, DJ; Lowe, J; Welch, SP
      Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception

      EUROPEAN JOURNAL OF PHARMACOLOGY
    26. Williams, CM; Kirkham, TC
      Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

      PSYCHOPHARMACOLOGY
    27. KIMURA T; OHTA T; WATANABE K; YOSHIMURA H; YAMAMOTO I
      ANANDAMIDE, AN ENDOGENOUS CANNABINOID RECEPTOR-LIGAND, ALSO INTERACTSWITH 5-HYDROXYTRYPTAMINE (5-HT) RECEPTOR

      Biological & pharmaceutical bulletin
    28. CHAKRABARTI A; EKUTA JE; ONAIVI ES
      NEUROBEHAVIORAL EFFECTS OF ANANDAMIDE AND CANNABINOID RECEPTOR GENE-EXPRESSION IN MICE

      Brain research bulletin
    29. RUSSO E
      CANNABIS FOR MIGRAINE TREATMENT - THE ONCE AND FUTURE PRESCRIPTION - AN HISTORICAL AND SCIENTIFIC REVIEW

      Pain
    30. SULCOVA E; MECHOULAM R; FRIDE E
      BIPHASIC EFFECTS OF ANANDAMIDE

      Pharmacology, biochemistry and behavior
    31. Di Marzo, V; Sepe, N; De Petrocellis, L; Berger, A; Crozier, G; Fride, E; Mechoulam, R
      Trick or treat from food endocannabinoids?

      NATURE
    32. EDGEMOND WS; HILLARD CJ; FALCK JR; KEARN CS; CAMPBELL WB
      HUMAN PLATELETS AND POLYMORPHONUCLEAR LEUKOCYTES SYNTHESIZE OXYGENATED DERIVATIVES OF ARACHIDONYLETHANOLAMIDE (ANANDAMIDE) - THEIR AFFINITIES FOR CANNABINOID RECEPTORS AND PATHWAYS OF INACTIVATION

      Molecular pharmacology
    33. ROMERO J; WENGER T; DEMIGUEL R; RAMOS JA; FERNANDEZRUIZ JJ
      CANNABINOID RECEPTOR-BINDING DID NOT VARY IN SEVERAL HYPOTHALAMIC NUCLEI AFTER HYPOTHALAMIC DEAFFERENTATION

      Life sciences (1973)
    34. MALLET PE; BENINGER RJ
      DELTA(9)-TETRAHYDROCANNABINOL, BUT NOT THE ENDOGENOUS CANNABINOID RECEPTOR-LIGAND ANANDAMIDE, PRODUCES CONDITIONED PLACE AVOIDANCE

      Life sciences
    35. ACETO MD; SCATES SM; RAZDAN RK; MARTIN BR
      ANANDAMIDE, AN ENDOGENOUS CANNABINOID, HAS A VERY-LOW PHYSICAL-DEPENDENCE POTENTIAL

      The Journal of pharmacology and experimental therapeutics
    36. LICHTMAN AH; WILEY JL; LAVECCHIA KL; NEVIASER ST; ARTHUR DB; WILSON DM; MARTIN BR
      EFFECTS OF SR 141716A AFTER ACUTE OR CHRONIC CANNABINOID ADMINISTRATION IN DOGS

      European journal of pharmacology
    37. WILEY JL; RYAN WJ; RAZDAN RK; MARTIN BR
      EVALUATION OF CANNABIMIMETIC EFFECTS OF STRUCTURAL ANALOGS OF ANANDAMIDE IN RATS

      European journal of pharmacology
    38. STENGEL PW; RIPPY MK; COCKERHAM SL; DEVANE WA; SILBAUGH SA
      PULMONARY ACTIONS OF ANANDAMIDE, AN ENDOGENOUS CANNABINOID RECEPTOR AGONIST, IN GUINEA-PIGS

      European journal of pharmacology
    39. BENSHABAT S; FRIDE E; SHESKIN T; TAMIRI T; RHEE MH; VOGEL Z; BISOGNO T; DEPETROCELLIS L; DIMARZO V; MECHOULAM R
      AN ENTOURAGE EFFECT - INACTIVE ENDOGENOUS FATTY-ACID GLYCEROL ESTERS ENHANCE 2-ARACHIDONOYL-GLYCEROL CANNABINOID ACTIVITY

      European journal of pharmacology
    40. MURILLORODRIGUEZ E; SANCHEZALAVEZ M; NAVARRO L; MARTINEZGONZALEZ D; DRUCKERCOLIN R; PROSPEROGARCIA O
      ANANDAMIDE MODULATES SLEEP AND MEMORY IN RATS

      Brain research
    41. MCGREGOR IS; ARNOLD JC; WEBER MF; TOPPLE AN; HUNT GE
      A COMPARISON OF DELTA(9)-THC AND ANANDAMIDE INDUCED C-FOS EXPRESSION IN THE RAT FOREBRAIN

      Brain research
    42. PREVOT V; RIALAS CM; CROIX D; SALZET M; DUPOUY JP; POULAIN P; BEAUVILLAIN JC; STEFANO GB
      MORPHINE AND ANANDAMIDE COUPLING TO NITRIC-OXIDE STIMULATES GNRH AND CRF RELEASE FROM RAT MEDIAN-EMINENCE - NEUROVASCULAR REGULATION

      Brain research
    43. BISOGNO T; MELCK D; DEPETROCELLIS L; BOBROV MY; GRETSKAYA NM; BEZUGLOV VV; SITACHITTA N; GERWICK WH; DIMARZO V
      ARACHIDONOYLSEROTONIN AND OTHER NOVEL INHIBITORS OF FATTY-ACID AMIDE HYDROLASE

      Biochemical and biophysical research communications (Print)
    44. GREEN K
      MARIJUANA SMOKING VS CANNABINOIDS FOR GLAUCOMA THERAPY

      Archives of ophthalmology
    45. KONDO S; SUGIURA T; KODAKA T; KUDO N; WAKU K; TOKUMURA A
      ACCUMULATION OF VARIOUS N-ACYLETHANOLAMINES INCLUDING N-ARACHIDONOYLETHANOLAMINE (ANANDAMIDE) IN CADMIUM CHLORIDE-ADMINISTERED RAT TESTIS

      Archives of biochemistry and biophysics (Print)
    46. RYAN WJ; BANNER WK; CROCKER PJ; MARTIN BR; RAZDAN RK
      SYNTHESIS OF (-2-METHYLARACHIDONYL-2'-FLUOROETHYLAMIDE AND (-)-2-METHYLARACHIDONYL-2'-FLUOROETHYLAMIDE (O-689)())

      Bioorganic & medicinal chemistry letters
    47. SULCOVA A
      CONCURRENT TREATMENT WITH VERAPAMIL SUPPRESSES IMMUNE AND BEHAVIORAL-RESPONSE TO ENDOGENOUS CANNABINOID ANANDAMIDE

      Human psychopharmacology
    48. WELCH SP
      CHARACTERIZATION OF ANANDAMIDE-INDUCED TOLERANCE - COMPARISON TO DELTA(9)-THC-INDUCED INTERACTIONS WITH DYNORPHINERGIC SYSTEMS

      Drug and alcohol dependence
    49. LAKE KD; MARTIN BR; KUNOS G; VARGA K
      CARDIOVASCULAR EFFECTS OF ANANDAMIDE IN ANESTHETIZED AND CONSCIOUS NORMOTENSIVE AND HYPERTENSIVE RATS

      Hypertension
    50. WILEY JL; GOLDEN KM; RYAN WJ; BALSTER RL; RAZDAN RK; MARTIN BR
      EVALUATION OF CANNABIMIMETIC DISCRIMINATIVE STIMULUS EFFECTS OF ANANDAMIDE AND METHYLATED FLUOROANANDAMIDE IN RHESUS-MONKEYS

      Pharmacology, biochemistry and behavior
    51. BLOOM AS; TERSHNER S; FULLER SA; STEIN EA
      CANNABINOID-INDUCED ALTERATIONS IN REGIONAL CEREBRAL BLOOD-FLOW IN THE RAT

      Pharmacology, biochemistry and behavior
    52. BELTRAMO M; STELLA N; CALIGNANO A; LIN SY; MAKRIYANNIS A; PIOMELLI D
      FUNCTIONAL-ROLE OF HIGH-AFFINITY ANANDAMIDE TRANSPORT, AS REVEALED BYSELECTIVE-INHIBITION

      Science
    53. HODGES LC; REGGIO PH; GREEN K
      EVIDENCE AGAINST CANNABINOID RECEPTOR INVOLVEMENT IN INTRAOCULAR-PRESSURE EFFECTS OF CANNABINOIDS IN RABBITS

      Ophthalmic research
    54. WAGNER JA; VARGA K; ELLIS EF; RZIGALINSKI BA; MARTIN BR; KUNOS G
      ACTIVATION OF PERIPHERAL CB1 CANNABINOID RECEPTORS IN HEMORRHAGIC-SHOCK

      Nature
    55. MECHOULAM R; FRIDE E; HANUS L; SHESKIN T; BISOGNO T; DIMARZO V; BAYEWITCH M; VOGEL Z
      ANANDAMIDE MAY MEDIATE SLEEP INDUCTION

      Nature
    56. WILLOUGHBY KA; MOORE SF; MARTIN BR; ELLIS EF
      THE BIODISPOSITION AND METABOLISM OF ANANDAMIDE IN MICE

      The Journal of pharmacology and experimental therapeutics
    57. LAKE KD; COMPTON DR; VARGA K; MARTIN BR; KUNOS G
      CANNABINOID-INDUCED HYPOTENSION AND BRADYCARDIA IN RATS IS MEDIATED BY CB1-LIKE CANNABINOID RECEPTORS

      The Journal of pharmacology and experimental therapeutics
    58. THOMPSON MD; CUPPS TL; WISE DS; WOTRING LL; TOWNSEND LB
      SYNTHESIS AND EVALUATION OF 6-(DIBROMOMETHYL)-5-NITROPYRIMIDINES AS POTENTIAL ANTITUMOR AGENTS

      Journal of medicinal chemistry
    59. RYAN WJ; BANNER WK; WILEY JL; MARTIN BR; RAZDAN RK
      POTENT ANANDAMIDE ANALOGS - THE EFFECT OF CHANGING THE LENGTH AND BRANCHING OF THE END PENTYL CHAIN

      Journal of medicinal chemistry
    60. SELTZMAN HH; FLEMING DN; THOMAS BF; GILLIAM AF; MCCALLION DS; PERTWEE RG; COMPTON DR; MARTIN BR
      SYNTHESIS AND PHARMACOLOGICAL COMPARISON OF DIMETHYLHEPTYL AND PENTYLANALOGS OF ANANDAMIDE

      Journal of medicinal chemistry
    61. MIKAWA Y; MATSUDA S; KANAGAWA T; TAJIKA T; UEDA N; MIMURA Y
      OCULAR ACTIVITY OF TOPICALLY ADMINISTERED ANANDAMIDE IN THE RABBIT

      Japanese Journal of Ophthalmology
    62. CALIGNANO A; LARANA G; BELTRAMO M; MAKRIYANNIS A; PIOMELLI D
      POTENTIATION OF ANANDAMIDE HYPOTENSION BY THE TRANSPORT INHIBITOR, AM404

      European journal of pharmacology
    63. BERDYSHEV EV; BOICHOT E; GERMAIN N; ALLAIN N; ANGER JP; LAGENTE V
      INFLUENCE OF FATTY-ACID ETHANOLAMIDES AND DELTA(9)-TETRAHYDROCANNABINOL ON CYTOKINE AND ARACHIDONATE RELEASE BY MONONUCLEAR-CELLS

      European journal of pharmacology
    64. BISOGNO T; SEPE N; DEPETROCELLIS L; MECHOULAM R; DIMARZO V
      THE SLEEP-INDUCING FACTOR OLEAMIDE IS PRODUCED BY MOUSE NEUROBLASTOMA-CELLS

      Biochemical and biophysical research communications
    65. WENGER T; JAMALI KA; JUANEDA C; LEONARDELLI J; TRAMU G
      ARACHIDONYL ETHANOLAMIDE (ANANDAMIDE) ACTIVATES THE PARVOCELLULAR PART OF HYPOTHALAMIC PARAVENTRICULAR NUCLEUS

      Biochemical and biophysical research communications
    66. MALLET PE; BENINGER RJ
      THE ENDOGENOUS CANNABINOID RECEPTOR AGONIST ANANDAMIDE IMPAIRS MEMORYIN RATS

      Behavioural pharmacology
    67. MECHOULAM R; BENSHABAT S; HANUS L; FRIDE E; VOGEL Z; BAYEWITCH M; SULCOVA AE
      ENDOGENOUS CANNABINOID LIGANDS - CHEMICAL AND BIOLOGICAL STUDIES

      Journal of lipid mediators and cell signalling
    68. SUGIURA T; KONDO S; SUKAGAWA A; TONEGAWA T; NAKANE S; YAMASHITA A; WAKU K
      N-ARACHIDONOYLETHANOLAMINE (ANANDAMIDE), AN ENDOGENOUS CANNABINOID RECEPTOR-LIGAND, AND RELATED LIPID MOLECULES IN THE NERVOUS TISSUES

      Journal of lipid mediators and cell signalling
    69. LANGSTEIN J; HOFSTADTER F; SCHWARZ H
      CIS-9,10-OCTADECENOAMIDE, AN ENDOGENOUS SLEEP-INDUCING CNS COMPOUND, INHIBITS LYMPHOCYTE-PROLIFERATION

      Research in immunology
    70. JARHO P; URTTI A; PATE DW; SUHONEN P; JARVINEN T
      INCREASE IN AQUEOUS SOLUBILITY, STABILITY AND IN-VITRO CORNEAL PERMEABILITY OF ANANDAMIDE BY HYDROXYPROPYL-8-CYCLODEXTRIN

      International journal of pharmaceutics
    71. FRIDE E; MECHOULAM R
      DEVELOPMENTAL ASPECTS OF ANANDAMIDE - ONTOGENY OF RESPONSE AND PRENATAL EXPOSURE

      Psychoneuroendocrinology
    72. DIMARZO V; DEPETROCELLIS L; SEPE N; BUONO A
      BIOSYNTHESIS OF ANANDAMIDE AND RELATED ACYLETHANOLAMIDES IN MOUSE J774 MACROPHAGES AND N-18 NEUROBLASTOMA-CELLS

      Biochemical journal
    73. MECHOULAM R
      ENDOGENOUS CANNABINOID LIGANDS

      Journal of neuroimmunology
    74. FRIDE E; MECHOULAM R
      ONTOGENIC DEVELOPMENT OF THE RESPONSE TO ANANDAMIDE AND DELTA(9)-TETRAHYDROCANNABINOL IN MICE

      Developmental brain research
    75. PATE DW; JARVINEN K; URTTI A; JARHO P; FICH M; MAHADEVAN V; JARVINEN T
      EFFECTS OF TOPICAL ANANDAMIDES ON INTRAOCULAR-PRESSURE IN NORMOTENSIVE RABBITS

      Life sciences
    76. ROMERO J; GARCIAPALOMERO E; LIN SY; RAMOS JA; MAKRIYANNIS A; FERNANDEZRUIZ JJ
      EXTRAPYRAMIDAL EFFECTS OF METHANANDAMIDE, AN ANALOG OF ANANDAMIDE, THE ENDOGENOUS CB1 RECEPTOR-LIGAND

      Life sciences
    77. THOMAS BF; ADAMS IB; MASCARELLA SW; MARTIN BR; RAZDAN RK
      STRUCTURE-ACTIVITY ANALYSIS OF ANANDAMIDE ANALOGS - RELATIONSHIP TO ACANNABINOID PHARMACOPHORE

      Journal of medicinal chemistry
    78. STEIN EA; FULLER SA; EDGEMOND WS; CAMPBELL WB
      PHYSIOLOGICAL AND BEHAVIORAL-EFFECTS OF THE ENDOGENOUS CANNABINOID, ARACHIDONYLETHANOLAMIDE (ANANDAMIDE), IN THE RAT

      British Journal of Pharmacology
    79. SUGIURA T; KONDO S; SUKAGAWA A; TONEGAWA T; NAKANE S; YAMASHITA A; WAKU K
      ENZYMATIC-SYNTHESIS OF ANANDAMIDE, AN ENDOGENOUS CANNABINOID RECEPTOR-LIGAND, THROUGH N-ACYLPHOSPHATIDYLETHANOLAMINE PATHWAY IN TESTIS - INVOLVEMENT OF CA2-DEPENDENT TRANSACYLASE AND PHOSPHODIESTERASE ACTIVITIES()

      Biochemical and biophysical research communications
    80. TERRANOVA JP; STORME JJ; LAFON N; PERIO A; RINALDICARMONA M; LEFUR G; SOUBRIE P
      IMPROVEMENT OF MEMORY IN RODENTS BY THE SELECTIVE CB1 CANNABINOID RECEPTOR ANTAGONIST, SR-141716

      Psychopharmacology
    81. FONTANA A; DIMARZO V; CADAS H; PIOMELLI D
      ANALYSIS OF ANANDAMIDE, AN ENDOGENOUS CANNABINOID SUBSTANCE, AND OF OTHER NATURAL N-ACYLETHANOLAMINES

      Prostaglandins, leukotrienes and essential fatty acids
    82. ELLIS EF; MOORE SF; WILLOUGHBY KA
      ANANDAMIDE AND DELTA(9)-THC DILATION OF CEREBRAL ARTERIOLES IS BLOCKED BY INDOMETHACIN

      American journal of physiology. Heart and circulatory physiology
    83. VELA G; RUIZGAYO M; FUENTES JA
      ANANDAMIDE DECREASES NALOXONE-PRECIPITATED WITHDRAWAL SIGNS IN MICE CHRONICALLY TREATED WITH MORPHINE

      Neuropharmacology
    84. FACCI L; DALTOSO R; ROMANELLO S; BURIANI A; SKAPER SD; LEON A
      MAST-CELLS EXPRESS A PERIPHERAL CANNABINOID RECEPTOR WITH DIFFERENTIAL SENSITIVITY TO ANANDAMIDE AND PALMITOYLETHANOLAMIDE

      Proceedings of the National Academy of Sciences of the United Statesof America
    85. PRILLER J; BRILEY EM; MANSOURI J; DEVANE WA; MACKIE K; FELDER CC
      MEAD ETHANOLAMIDE, A NOVEL EICOSANOID, IS AN AGONIST FOR THE CENTRAL (CB1) AND PERIPHERAL (CB2) CANNABINOID RECEPTORS

      Molecular pharmacology
    86. ROMERO J; GARCIA L; CEBEIRA M; ZADROZNY D; FERNANDEZRUIZ JJ; RAMOS JA
      THE ENDOGENOUS CANNABINOID RECEPTOR-LIGAND, ANANDAMIDE, INHIBITS THE MOTOR BEHAVIOR - ROLE OF NIGROSTRIATAL DOPAMINERGIC-NEURONS

      Life sciences
    87. ADAMS IB; RYAN W; SINGER M; RAZDAN RK; COMPTON DR; MARTIN BR
      PHARMACOLOGICAL AND BEHAVIORAL-EVALUATION OF ALKYLATED ANANDAMIDE ANALOGS

      Life sciences
    88. MARTIN WJ; PATRICK SL; COFFIN PO; TSOU K; WALKER JM
      AN EXAMINATION OF THE CENTRAL SITES OF ACTION OF CANNABINOID-INDUCED ANTINOCICEPTION IN THE RAT

      Life sciences
    89. HOHMANN AG; MARTIN WJ; TSOU K; WALKER JM
      INHIBITION OF NOXIOUS STIMULUS-EVOKED ACTIVITY OF SPINAL-CORD DORSAL HORN NEURONS BY THE CANNABINOID WIN 55,212-2

      Life sciences
    90. LEE M; YANG KH; KAMINSKI NE
      EFFECTS OF PUTATIVE CANNABINOID RECEPTOR LIGANDS, ANANDAMIDE AND 2-ARACHIDONYL-GLYCEROL, ON IMMUNE FUNCTION IN B6C3F1 MOUSE SPLENOCYTES

      The Journal of pharmacology and experimental therapeutics
    91. ADAMS IB; RYAN W; SINGER M; THOMAS BF; COMPTON DR; RAZDAN RK; MARTIN BR
      EVALUATION OF CANNABINOID RECEPTOR-BINDING AND IN-VIVO ACTIVITIES FORANANDAMIDE ANALOGS

      The Journal of pharmacology and experimental therapeutics
    92. WELCH SP; DUNLOW LD; PATRICK GS; RAZDAN RK
      CHARACTERIZATION OF ANANDAMIDE-INDUCED AND FLUOROANANDAMIDE-INDUCED ANTINOCICEPTION AND CROSS-TOLERANCE TO DELTA(9)-THC AFTER INTRATHECAL ADMINISTRATION TO MICE - BLOCKADE OF DELTA(9)-THC-INDUCED ANTINOCICEPTION

      The Journal of pharmacology and experimental therapeutics
    93. FRIDE E; BARG J; LEVY R; SAYA D; HELDMAN E; MECHOULAM R; VOGEL Z
      LOW-DOSES OF ANANDAMIDES INHIBIT PHARMACOLOGICAL EFFECTS OF DELTA(9)-TETRAHYDROCANNABINOL

      The Journal of pharmacology and experimental therapeutics
    94. BARG J; FRIDE E; HANUS L; LEVY R; MATUSLEIBOVITCH N; HELDMAN E; BAYEWITCH M; MECHOULAM R; VOGEL Z
      CANNABINOMIMETIC BEHAVIORAL-EFFECTS OF AND ADENYLATE-CYCLASE INHIBITION BY 2 NEW ENDOGENOUS ANANDAMIDES

      European journal of pharmacology
    95. WILEY J; BALSTER R; MARTIN B
      DISCRIMINATIVE STIMULUS EFFECTS OF ANANDAMIDE IN RATS

      European journal of pharmacology
    96. FRIDE E
      ANANDAMIDES - TOLERANCE AND CROSS-TOLERANCE TO DELTA(9)-TETRAHYDROCANNABINOL

      Brain research
    97. ROMERO J; DEMIGUEL R; GARCIAPALOMERO E; FERNANDEZRUIZ JJ; RAMOS JA
      TIME-COURSE OF THE EFFECTS OF ANANDAMIDE, THE PUTATIVE ENDOGENOUS CANNABINOID RECEPTOR-LIGAND, ON EXTRAPYRAMIDAL FUNCTION

      Brain research
    98. ANDERSON LA; ANDERSON JJ; CHASE TN; WALTERS JR
      THE CANNABINOID AGONISTS WIN-55,212-2 AND CP-55,940 ATTENUATE ROTATIONAL BEHAVIOR INDUCED BY A DOPAMINE D-1 BUT NOT A D-2 AGONIST IN RATS WITH UNILATERAL LESIONS OF THE NIGROSTRIATAL PATHWAY

      Brain research
    99. GUZMAN M; FERNANDEZRUIZ JJ; SANCHEZ C; VELASCO G; RAMOS JA
      EFFECTS OF ANANDAMIDE ON HEPATIC FATTY-ACID METABOLISM

      Biochemical pharmacology
    100. MECHOULAM R; BENSHABAT S; HANUS L; LIGUMSKY M; KAMINSKI NE; SCHATZ AR; GOPHER A; ALMOG S; MARTIN BR; COMPTON DR; PERTWEE RG; GRIFFIN G; BAYEWITCH M; BARG J; VOGEL Z
      IDENTIFICATION OF AN ENDOGENOUS 2-MONOGLYCERIDE, PRESENT IN CANINE GUT, THAT BINDS TO CANNABINOID RECEPTORS

      Biochemical pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 01:31:52